Mark Bearn and Helen Marshall, based at Tile Hill, examine healthcare workers and their mental health, making a case for building resilience into our care systems.
Dr Placide Mbala-Kingebeni and Prof Jean-Jacques Muyembe Tamfum, discuss the contribution of pathogen sequencing in the management of infectious disease epidemics in the Democratic Republic of Congo.
Dr. Malcolm Doupe and Dr. Frode Fadnes Jacobsen present their joint research program in response to the World Health Organization’s Global Strategy and Action Plan on Ageing and Health.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, offers preliminary context about the impact of the COVID-19 pandemic in most African countries, starting with lessons to be learned from previous outbreaks.
Chris Lynch, Deputy CEO at Alzheimer’s Disease International, sheds light on the WHO Global action plan on the public health response to dementia 2017-2025.
A new editorial, published across 220 journals, expresses the climate concerns of healthcare professionals and researchers - with Dr Ghebreyesus saying "there is no vaccine for the climate crisis".
Leo Braack, Malaria Consortium’s Senior Vector Control Specialist, recounts the ongoing battle against vector-borne diseases and shares why the need for new mosquito control tools has become critical.
Dr Tedros Ghebreyesus, WHO leader, asked richer countries in the Global North to wait before giving third COVID jabs - as the Global South is yet to hit 10% double-vaccinated, due to low vaccine supply.
The World Health Organisation says that double-vaccinated people should wear masks due to the rising threat of the Delta variant, as the UK considers dropping mandatory mask measures after 'unlockdown'.
Open Access Government caught up with Dr Mary Stephen, Public Health Expert at the World Health Organization African Region, provides an update on the COVID-19 outbreak in Africa.
Florence Fouque from the World Health Organization describes the unpredictability and risks of health systems disruptions due to the impact of climate change on vectors & vector-borne diseases.
The World Health Organisation (WHO) has given emergency approval to the Sinovac COVID-19 vaccine - because there is ongoing "access inequity" for countries in the Global South.
The WHO has renamed COVID variants of concern, as they believe that the scientific names can be "difficult" to use - leading to both misreporting and potential discrimination against countries of origin.
Rachel Thrasher, Research Fellow at the Global Development Policy Center in Boston, explains how the TRIPS COVID-19 waiver rejected by the WTO could ramp up global vaccine production.
